[HTML][HTML] Nanoemulsions for drug delivery

RJ Wilson, Y Li, G Yang, CX Zhao - Particuology, 2022 - Elsevier
Emulsions are liquid–liquid dispersions with one liquid phase dispersed in the other liquid
phase as small droplets. Nanoemulsions are nano-sized emulsions with sizes ranging from …

Current applications of nanoemulsions in cancer therapeutics

E Sánchez-López, M Guerra, J Dias-Ferreira… - Nanomaterials, 2019 - mdpi.com
Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer
range. They possess the capacity to encapsulate drugs that are poorly water soluble due to …

Theranostic application of nanoemulsions in chemotherapy

B Gorain, H Choudhury, AB Nair, SK Dubey… - Drug discovery today, 2020 - Elsevier
Highlights•Theranostic nanoemulsions hold possibilities to detect and treat cancer
effectively.•Targeting theranostic approaches received great attention for site-specific …

Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer

J Halder, D Pradhan, B Kar, G Ghosh, G Rath - … , Biology and Medicine, 2022 - Elsevier
Multidrug resistance (MDR) in cancer chemotherapy is a growing concern for medical
practitioners. P-glycoprotein (P-gp) overexpression is one of the major reasons for multidrug …

Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years

NA D'Angelo, MA Noronha, MCC Câmara… - Biomaterials …, 2022 - Elsevier
Doxorubicin (DOX) is a natural antibiotic with antineoplastic activity. It has been used for
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …

Emerging targeted drug delivery strategies toward ovarian cancer

Z Wang, F Meng, Z Zhong - Advanced Drug Delivery Reviews, 2021 - Elsevier
Ovarian cancer is a high-mortality malignancy in women. The contemporary clinical
chemotherapy with classic cytotoxic drugs, targeted molecular inhibitors would mostly fail …

Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology

H Choudhury, M Pandey, TH Yin, T Kaur, GW Jia… - Materials Science and …, 2019 - Elsevier
Multidrug resistance (MDR) is one of the key barriers in chemotherapy, leading to the
generation of insensitive cancer cells towards administered therapy. Genetic and epigenetic …

Lipid based drug delivery systems for oral, transdermal and parenteral delivery: recent strategies for targeted delivery consistent with different clinical application

AK Srivastav, S Karpathak, MK Rai, D Kumar… - Journal of Drug Delivery …, 2023 - Elsevier
Lipid based drug delivery systems (LBDDS) are valuable and biocompatible nano-carriers
for the vehiculation and potential delivery of various hydrophilic, hydrophobic, or amphiphilic …

Pulmonary delivery of anticancer drugs via lipid-based nanocarriers for the treatment of lung cancer: An update

IM Abdulbaqi, RA Assi, A Yaghmur, Y Darwis… - Pharmaceuticals, 2021 - mdpi.com
Lung cancer (LC) is the leading cause of cancer-related deaths, responsible for
approximately 18.4% of all cancer mortalities in both sexes combined. The use of systemic …

Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells

MH Alkhatib, RS Bawadud, HM Gashlan - Scientific reports, 2020 - nature.com
Combining more than one anticancer agent in a nanocarrier is beneficial in producing a
formula with a low dose and limited adverse side effects. The current study aimed to …